These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27774031)

  • 1. Remission, response, and relapse rates in patients with acute schizophrenia treated with olanzapine monotherapy or other atypical antipsychotic monotherapy: 12-month prospective observational study.
    Takahashi M; Nakahara N; Fujikoshi S; Iyo M
    Pragmat Obs Res; 2015; 6():39-46. PubMed ID: 27774031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
    Dossenbach M; Arango-Dávila C; Silva Ibarra H; Landa E; Aguilar J; Caro O; Leadbetter J; Assunção S
    J Clin Psychiatry; 2005 Aug; 66(8):1021-30. PubMed ID: 16086618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con Olanzapina.
    Sacristán JA; Gómez JC; Montejo AL; Vieta E; Gregor KJ
    Clin Ther; 2000 May; 22(5):583-99. PubMed ID: 10868556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of tardive dyskinesia in older adult patients treated with olanzapine or conventional antipsychotics.
    Kinon BJ; Kollack-Walker S; Jeste D; Gupta S; Chen L; Case M; Chen J; Stauffer V
    J Geriatr Psychiatry Neurol; 2015 Mar; 28(1):67-79. PubMed ID: 25009161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia.
    Hatta K; Otachi T; Fujita K; Morikawa F; Ito S; Tomiyama H; Abe T; Sudo Y; Takebayashi H; Yamashita T; Katayama S; Nakase R; Shirai Y; Usui C; Nakamura H; Ito H; Hirata T; Sawa Y;
    Schizophr Res; 2014 Sep; 158(1-3):213-22. PubMed ID: 25086659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis.
    Ye W; Ascher-Svanum H; Tanji Y; Flynn JA; Takahashi M; Conley RR
    Neuropsychiatr Dis Treat; 2012; 8():259-66. PubMed ID: 22745559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severely psychotic inpatients with schizophrenia: olanzapine versus other antipsychotic drugs.
    Carrasco JL; Gutiérrez M; Gómez JC; Escobar R; Alvarez E; Cañas F; Bobes J; Gascón J; Gibert J
    Int Clin Psychopharmacol; 2002 Nov; 17(6):287-95. PubMed ID: 12409682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients.
    Bobes J; Gibert J; Ciudad A; Alvarez E; Cañas F; Carrasco JL; Gascón J; Gómez JC; Gutiérrez M
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):473-81. PubMed ID: 12691783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses.
    Ciudad A; Anand E; Berggren L; Casillas M; Schacht A; Perrin E
    Neuropsychiatr Dis Treat; 2013; 9():1737-50. PubMed ID: 24235837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo pharmacological evaluations of novel olanzapine analogues in rats: a potential new avenue for the treatment of schizophrenia.
    Jafari S; Huang XF; Andrews JL; Fernandez-Enright F
    PLoS One; 2013; 8(12):e80979. PubMed ID: 24349027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Olanzapine and Samidorphan Has No Clinically Significant Effect on the Pharmacokinetics of Lithium or Valproate.
    Sun L; Yagoda S; Yao B; Graham C; von Moltke L
    Clin Drug Investig; 2020 Jan; 40(1):55-64. PubMed ID: 31584140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan.
    Ye W; Ascher-Svanum H; Flynn JA; Tanji Y; Takahashi M
    Clinicoecon Outcomes Res; 2012; 4():13-9. PubMed ID: 22347801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia.
    Tajiri M; Suzuki Y; Sugai T; Tsuneyama N; Someya T
    PLoS One; 2018; 13(7):e0199922. PubMed ID: 30016331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial.
    Tunis SL; Faries DE; Nyhuis AW; Kinon BJ; Ascher-Svanum H; Aquila R
    Value Health; 2006; 9(2):77-89. PubMed ID: 16626411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats.
    Porter JH; McCallum SE; Varvel SA; Vann RE
    Psychopharmacology (Berl); 2000 Feb; 148(3):224-33. PubMed ID: 10755735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine/Samidorphan: A New Option for the Treatment of Adults With Schizophrenia or Bipolar I Disorder.
    Pham H; Warlick H; Bermudez R; Nguyen Q; Rey JA
    J Pharm Technol; 2022 Oct; 38(5):304-313. PubMed ID: 36046346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study.
    Potkin SG; Kunovac J; Silverman BL; Simmons A; Jiang Y; DiPetrillo L; McDonnell D
    J Clin Psychiatry; 2020 Mar; 81(2):. PubMed ID: 32141723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations.
    Crawford AM; Beasley CM; Tollefson GD
    Schizophr Res; 1997 Jul; 26(1):41-54. PubMed ID: 9376336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.